SKYRIZI 360 MG/2.4 ML ON-BODY | Missouri Department of Social Services

Generic Name

RISANKIZUMAB-RZAA

Review Date Began

Sun, 06/26/2022 - 12:00

Review Date Completed

Thu, 08/11/2022 - 12:00

Conclusion

Clinical Edit

Committee Month

Thu, 09/01/2022 - 12:00

Sat, 10/01/2022 - 12:00